The table below shows IRADIMED CORP's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$21.98M
$21.20M
$20.41M
$19.51M
$18.33M
$17.93M
Cost of revenue
$5.17M
$4.71M
$4.45M
$4.67M
$4.13M
$3.92M
Gross profit
$16.81M
$16.49M
$15.95M
$14.84M
$14.19M
$14.01M
R&D
$956.00K
$674.36K
$877.36K
$624.00K
$639.47K
$801.13K
IRMD annual revenue (10-K history)
IRADIMED CORP reported annual revenue of $83.81M for fiscal year 2025. That is up 14.4% from $73.24M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $32.50M (FY 2016) to $83.81M. Figures come from the company's audited annual reports as filed with the SEC.